For severe pancreatitis, gastrointestinal fistula
2 ℃-8 ℃ refrigerator storage
Octreotide is a synthetic Octreotide derivative of natural somatostatin. Its pharmacological action is similar to somatostatin, but its action lasts longer. This product has many kinds of physiological activities, such as inhibiting growth hormone and promoting thyroid hormone. It can inhibit the secretion of gastric acid, pancreatic enzyme, glucagon and insulin. It can reduce gastric motility and gallbladder emptying, inhibit the secretion of cholecystokin-pancreatic enzyme, reduce pancreatic secretion, and have direct protective effects on pancreatic parenchymal cell membrane. Reduce viscera blood flow, reduce portal pressure, reduce excessive intestinal secretion, and increase intestinal absorption of water and sodium.
Used for acromegaly. Emergency treatment of esophageal - gastric varicose bleeding caused by liver cirrhosis in combination with special treatment such as endoscopic hardener therapy. Prevent postoperative complications of pancreas. Relieve symptoms and signs related to gastrointestinal endocrine tumors.
The main adverse reactions are pain or tingling at the injection site, which can usually be relieved after 15 minutes. Adverse reactions in the digestive tract include anorexia, nausea, vomiting, diarrhea, abdominal cramps and pain, and occasionally high blood sugar, gallstones, abnormal glucose tolerance and abnormal liver function.
Matters needing attention
Use with caution in patients with renal and pancreatic dysfunction and cholelithiasis. In patients with insulin-dependent diabetes or with diabetes, blood glucose levels should be closely monitored.